MARKET

PPH

PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

73.30
-0.53
-0.72%
Opening 12:36 09/16 EDT
OPEN
73.97
PREV CLOSE
73.83
HIGH
73.97
LOW
73.23
VOLUME
34.65K
TURNOVER
--
52 WEEK HIGH
77.46
52 WEEK LOW
58.35
TOTAL ASSET
341.20M
YTD YIELD
-1.48%
1D
5D
1M
3M
1Y
5Y
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Zacks.com · 6d ago
Big pharma extends losses as drug pricing debate heats up
Big-cap pharma stocks are trading lower on Monday as news reports emerge over the measures being taken in Washington to contain prescription drug pricing. Health Care Select Sect SPDR ETF
Seekingalpha · 09/09 16:12
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Zacks.com · 08/18 10:20
Best Pharmaceutical ETFs for Q4 2021
Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure dise...
Investopedia · 08/17 19:26
Pharma ETFs Gain on Q2 Earnings
Zacks.com · 08/06 14:05
Sanofi to Buy mRNA Developer: ETFs in Focus
Zacks.com · 08/04 18:30
Pharma & Healthcare ETFs at a One-Year High: Here's Why
Zacks.com · 07/30 12:00
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.2859
VanEck Vectors Pharmaceutical ETF (PPH) - $0.2859.30-Day SEC Yield of 1.63% as of June 30.Payable Jul 08; for shareholders of record Jul 02; ex-div Jul 01.
Seekingalpha · 07/01 18:29
More
No Data
Learn about the latest financial forecast of PPH. Analyze the recent business situations of VanEck Vectors Pharmaceutical ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.1712%
--
1-Week
-2.4151%
--
1-Month
-2.9895%
--
3-Month
-1.3098%
--
6-Month
4.8724%
--
YTD
-1.4781%
--
1-Year
12.4328%
--
3-Year
5.9871%
--
5-Year
0.5642%
--
Since Inception
8.8357%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin